PWAM
RIGL icon

Private Wealth Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Private Wealth Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.9K Buy
700
+400
+133% +$13.4K ﹤0.01% 574
2025
Q4 		$12.8K Hold
300
– – ﹤0.01% 625
2025
Q3 		$8.5K Buy
+300
New +$8.97K ﹤0.01% 676

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Wealth Asset Management's RIGL Position: Q1 2026 in Review

Private Wealth Asset Management increased its Rigel Pharmaceuticals (RIGL) stake by 133% in Q1 2026, buying an estimated $13.4K and bringing the position to 700 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Private Wealth Asset Management first reported a position in RIGL in Q3 2025 and has held it in 3 quarters since. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Private Wealth Asset Management held 700 shares of Rigel Pharmaceuticals worth $18.9K as of Q1 2026.
  • Private Wealth Asset Management bought 400 Rigel Pharmaceuticals shares in Q1 2026, an estimated $13.4K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q1 2026, its #574 holding.
  • Private Wealth Asset Management first reported a position in Rigel Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Private Wealth Asset Management's 13F filing for Q1 2026, filed 6 May 2026.